AU8604598A - Pharmaceutical formulation for camptothecin analogues in gelatin capsule - Google Patents

Pharmaceutical formulation for camptothecin analogues in gelatin capsule

Info

Publication number
AU8604598A
AU8604598A AU86045/98A AU8604598A AU8604598A AU 8604598 A AU8604598 A AU 8604598A AU 86045/98 A AU86045/98 A AU 86045/98A AU 8604598 A AU8604598 A AU 8604598A AU 8604598 A AU8604598 A AU 8604598A
Authority
AU
Australia
Prior art keywords
pharmaceutical formulation
gelatin capsule
camptothecin analogues
camptothecin
analogues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU86045/98A
Inventor
Gregory A. Christensen
Nageswara R Palepu
Kamlesh Patel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of AU8604598A publication Critical patent/AU8604598A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU86045/98A 1997-08-01 1998-07-30 Pharmaceutical formulation for camptothecin analogues in gelatin capsule Abandoned AU8604598A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US90476197A 1997-08-01 1997-08-01
US08904761 1997-08-01
PCT/US1998/015908 WO1999006031A1 (en) 1997-08-01 1998-07-30 Pharmaceutical formulation for camptothecin analogues in gelatin capsule

Publications (1)

Publication Number Publication Date
AU8604598A true AU8604598A (en) 1999-02-22

Family

ID=25419727

Family Applications (1)

Application Number Title Priority Date Filing Date
AU86045/98A Abandoned AU8604598A (en) 1997-08-01 1998-07-30 Pharmaceutical formulation for camptothecin analogues in gelatin capsule

Country Status (5)

Country Link
AR (1) AR013261A1 (en)
AU (1) AU8604598A (en)
CO (1) CO4970695A1 (en)
WO (1) WO1999006031A1 (en)
ZA (1) ZA986877B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6281223B1 (en) 1999-04-13 2001-08-28 Supergen, Inc. Radioenhanced camptothecin derivative cancer treatments
GB9918885D0 (en) * 1999-08-10 1999-10-13 Pharmacia & Upjohn Spa Pharmaceutical formulations in hydroxypropymethycellulose capsules
AU2005222541B2 (en) * 1999-08-10 2008-07-24 Pharmacia & Upjohn S.P.A. Pharmaceutical formulations in hydroxypropylmethylcellulose capsules
GB9925127D0 (en) * 1999-10-22 1999-12-22 Pharmacia & Upjohn Spa Oral formulations for anti-tumor compounds
TWI333492B (en) * 2003-11-12 2010-11-21 Smithkline Beecham Cork Ltd Crystalline topotecan hydrochloride product and preparation thereof
GT200500310A (en) 2004-11-19 2006-06-19 ORGANIC COMPOUNDS
SA06270147B1 (en) 2005-06-09 2009-12-22 نوفارتيس ايه جي Process for the Synthesis Of 5-(methyl-1h-imidazol-1-yl)-3-(trifluoromethyl)-benzenamine
ITRM20050418A1 (en) * 2005-08-04 2007-02-05 Sigma Tau Ind Farmaceuti IMMEDIATE RELEASE THERAPEUTIC SYSTEMS FOR THE IMPROVED ORAL ABSORPTION OF 7 - [(E) -T-BUTYLOSSIMINOMETHYL] CAMPTOTECIN.
JP2013545800A (en) * 2010-12-20 2013-12-26 コルゲート・パーモリブ・カンパニー Gelatin encapsulated oral care composition comprising a hydrophilic active agent, a hydrophobic structurant and an oil carrier
CA2821371A1 (en) 2010-12-20 2012-06-28 Colgate-Palmolive Company Gelatin encapsulated oral care composition containing dental occlusion actives, hydrophobic viscosity modifier and oil carrier
BR112013015574B1 (en) 2010-12-20 2018-02-06 Colgate-Palmolive Company Non-aqueous oral care composition containing dental occlusion actives, teeth cleaning method and toothbrush

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8904182D0 (en) * 1989-02-23 1989-04-05 Glaxo Canada Pharmaceutical compositions
US5225404A (en) * 1989-11-06 1993-07-06 New York University Methods of treating colon tumors with tumor-inhibiting camptothecin compounds
US5468754A (en) * 1994-04-19 1995-11-21 Bionumerik Pharmaceuticals, Inc. 11,7 substituted camptothecin derivatives and formulations of 11,7 substituted camptothecin derivatives and methods for uses thereof
US5677286A (en) * 1995-04-27 1997-10-14 The University Of Michigan Glycosylated analogs of camptothecin

Also Published As

Publication number Publication date
CO4970695A1 (en) 2000-11-07
ZA986877B (en) 1999-06-15
AR013261A1 (en) 2000-12-13
WO1999006031A1 (en) 1999-02-11

Similar Documents

Publication Publication Date Title
GB9519363D0 (en) Pharmaceutical formulation
ZA982872B (en) Pharmaceutical formulation
HUP0100179A3 (en) Imidazopyrimidine and imidazopyridine derivatives and pharmaceutical compositions thereof
AU7375598A (en) Stable oral pharmaceutical dosage forms
HK1015697A1 (en) Stable freeze-dried pharmaceutical formulation
HUP0100178A3 (en) Tetrahydro-naphtiridinyl-imidazolydinyl-carboxylic acid derivatives and pharmaceutical compositions thereof
AU9224498A (en) Matrix for controlled delivery of highly soluble drugs
EP0862431A4 (en) Pharmaceutical formulation
IL125020A0 (en) Pharmaceutical compositions with vitamin d analogues
AU7454698A (en) Improvement in medicament administration system
AU8604598A (en) Pharmaceutical formulation for camptothecin analogues in gelatin capsule
HUP0100085A3 (en) Biphenylamidine derivatives and pharmaceutical compositions containing them
IL134538A (en) Lactacystin derivatives and pharmaceutical compositions containing the same
GB9918885D0 (en) Pharmaceutical formulations in hydroxypropymethycellulose capsules
ZA982073B (en) Pharmaceutical preparation
AU6940998A (en) Phospholipid drug derivatives
GB9523566D0 (en) Pharmaceutical formulation
IL132986A0 (en) Rapamycin formulation for oral administration
AU3953197A (en) Catechol amino acid derivatives and pharmaceutical compositions containing them
GB9709739D0 (en) Pharmaceutical formulation
ZA981775B (en) Pharmaceutical formulations containing poorly soluble drug substances
AU3860797A (en) Pharmaceutical formulations for oral administration
HUP0004132A3 (en) Rapidly soluble drug composition
AU5182099A (en) Pharmaceutical formulation
AU7799198A (en) Method for preparing pharmaceutical formulation

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase